The Association of Small Dense Low-Density Lipoprotein Cholesterol and Coronary Heart Disease in Subjects at High Cardiovascular Risk.
Coronary heart disease
High-risk population
Prospective study
Risk assessment
Small dense LDL cholesterol
Journal
Journal of atherosclerosis and thrombosis
ISSN: 1880-3873
Titre abrégé: J Atheroscler Thromb
Pays: Japan
ID NLM: 9506298
Informations de publication
Date de publication:
01 Jan 2021
01 Jan 2021
Historique:
pubmed:
21
4
2020
medline:
15
10
2021
entrez:
21
4
2020
Statut:
ppublish
Résumé
The present study aims to investigate the association between serum small dense low-density lipoprotein (sdLDL) cholesterol level and the development of coronary heart disease (CHD) in subjects at high cardiovascular risk. A total of 3,080 participants without prior cardiovascular disease (CVD), aged ≥ 40 years, were followed up for a median of 8.3 years, which were divided into two groups, those with serum sdLDL cholesterol levels of <35 mg/dL or ≥ 35 mg/dL. Then, subjects were stratified by the status of diabetes, CVD-related comorbidities (defined as the presence of diabetes, chronic kidney disease, or peripheral artery disease), and the CVD risk assessment according to the Japan Atherosclerosis Society Guidelines. The hazard ratios (HRs) and 95% confidence intervals (CIs) were computed using a Cox proportional hazards model. During the follow-up, 79 subjects developed CHD. The risk for incident CHD was higher in subjects with serum sdLDL cholesterol of ≥ 35 mg/dL than those with sdLDL cholesterol of <35 mg/dL (HR 2.09, 95%CI 1.26-3.45) after adjusting for traditional risk factors. In the subgroup analyses, the multivariable-adjusted HR for incident CHD increased significantly in those with serum sdLDL cholesterol of ≥ 35 mg/dL among subjects with diabetes (HR 2.76, 95%CI 1.09-7.01), subjects with CVD-related comorbidities (HR 2.60, 95%CI 1.21-5.58), and high-risk category defined as the presence of CVD-related comorbidities or a Suita score of ≥ 56 points (HR 1.93, 95%CI 1.02-3.65). Elevated serum sdLDL cholesterol was associated with the development of CHD even in subjects at high cardiovascular risk.
Identifiants
pubmed: 32307338
doi: 10.5551/jat.55350
pmc: PMC7875148
doi:
Substances chimiques
Biomarkers
0
Cholesterol, LDL
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
79-89Références
Lancet. 2018 Nov 10;392(10159):1736-1788
pubmed: 30496103
J Atheroscler Thromb. 2013;20(2):195-203
pubmed: 23076217
J Lipid Res. 2003 Nov;44(11):2193-201
pubmed: 12897184
Am J Med. 2001 Feb 1;110(2):103-10
pubmed: 11165551
Arterioscler Thromb Vasc Biol. 2014 May;34(5):1069-77
pubmed: 24558110
Circulation. 2013 Sep 10;128(11):1198-205
pubmed: 23902756
J Atheroscler Thromb. 2018 Sep 1;25(9):846-984
pubmed: 30135334
Am J Med. 2001 Dec 1;111(8):633-42
pubmed: 11755507
Eur Heart J. 2007 Oct;28(20):2525-38
pubmed: 17951287
J Atheroscler Thromb. 2014;21(8):784-98
pubmed: 24671110
Clin Chem. 2011 Jan;57(1):57-65
pubmed: 21051530
J Lipid Res. 1998 Jun;39(6):1263-73
pubmed: 9643358
Atherosclerosis. 1996 Aug 2;124(2):261-71
pubmed: 8830938
J Atheroscler Thromb. 2020 Jul 1;27(7):669-682
pubmed: 31708527
J Epidemiol. 2018 Nov 5;28(11):444-451
pubmed: 30298863
Lancet. 2005 Oct 8;366(9493):1267-78
pubmed: 16214597
Arterioscler Thromb Vasc Biol. 2014 Jan;34(1):196-201
pubmed: 24233487
Am J Kidney Dis. 2010 Jul;56(1):32-8
pubmed: 20416999